Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tilg

Showing results (51-60 of 141) with videos related to

Pageof 15
Sort By:
Blood|January 1, 1994
Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55H Tilg, E Trehu, M B Atkins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1993
Induction of circulating and erythrocyte-bound IL-8 by IL-2 immunotherapy and suppression of its in vitro production by IL-1 receptor antagonist and soluble tumor necrosis factor receptor (p75) chimeraH Tilg, L Shapiro, M B Atkins, et al.
Wiener Klinische Wochenschrift|January 22, 1988
Cytomegalovirus infectionW E Aulitzky, P Hengster, H Tilg, et al.
Biochemical and Biophysical Research Communications|September 3, 2003
Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitroS Kaser, A Kaser, A Sandhofer, et al.
Zeitschrift Fur Gastroenterologie|September 3, 2013
[Adalimumab for the treatment of adult Crohn's disease--update of a consensus report by the Working Group Inflammatory Bowel Disease of the Austrian Society of Gastroenterology and Hepatology]G Novacek, T Haas, P Knoflach, et al.
European Cytokine Network|September 22, 2001
Activation of caspase-3 by interferon alpha causes interleukin-16 secretion but fails to modulate activation induced cell deathO Ludwiczek, A Kaser, R O Koch, et al.
Zeitschrift Fur Gastroenterologie|August 19, 2007
[Use of infliximab in ulcerative colitis]H Tilg, T Feichtenschlager, P Knoflach, et al.
Transplantation Proceedings|June 1, 1992
Pancreatic juice neopterin excretion--a reliable marker of pancreas allograft rejectionA Königsrainer, H Tilg, G Reibnegger, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 30, 2000
In vivo effects of recombinant human interleukin-10 on lymphocyte phenotypes and leukocyte activation markers in inflammatory bowel diseaseC Dejaco, W Reinisch, C Lichtenberger, et al.
Gastroenterology|July 1, 1992
Serum levels of cytokines in chronic liver diseasesH Tilg, A Wilmer, W Vogel, et al.
Pageof 15

Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
Blood|January 1, 1994
Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55H Tilg, E Trehu, M B Atkins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1993
Induction of circulating and erythrocyte-bound IL-8 by IL-2 immunotherapy and suppression of its in vitro production by IL-1 receptor antagonist and soluble tumor necrosis factor receptor (p75) chimeraH Tilg, L Shapiro, M B Atkins, et al.
Wiener Klinische Wochenschrift|January 22, 1988
Cytomegalovirus infectionW E Aulitzky, P Hengster, H Tilg, et al.
Biochemical and Biophysical Research Communications|September 3, 2003
Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitroS Kaser, A Kaser, A Sandhofer, et al.
Zeitschrift Fur Gastroenterologie|September 3, 2013
[Adalimumab for the treatment of adult Crohn's disease--update of a consensus report by the Working Group Inflammatory Bowel Disease of the Austrian Society of Gastroenterology and Hepatology]G Novacek, T Haas, P Knoflach, et al.
European Cytokine Network|September 22, 2001
Activation of caspase-3 by interferon alpha causes interleukin-16 secretion but fails to modulate activation induced cell deathO Ludwiczek, A Kaser, R O Koch, et al.
Zeitschrift Fur Gastroenterologie|August 19, 2007
[Use of infliximab in ulcerative colitis]H Tilg, T Feichtenschlager, P Knoflach, et al.
Transplantation Proceedings|June 1, 1992
Pancreatic juice neopterin excretion--a reliable marker of pancreas allograft rejectionA Königsrainer, H Tilg, G Reibnegger, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 30, 2000
In vivo effects of recombinant human interleukin-10 on lymphocyte phenotypes and leukocyte activation markers in inflammatory bowel diseaseC Dejaco, W Reinisch, C Lichtenberger, et al.
Gastroenterology|July 1, 1992
Serum levels of cytokines in chronic liver diseasesH Tilg, A Wilmer, W Vogel, et al.
Pageof 15